Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
July 13 2022 - 4:26PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of July 2022
Commission
File Number: 001-39034
BELLUS
HEALTH INC.
(Name
of registrant)
275
Armand-Frappier Blvd.
Laval,
Québec
H7V
4A7
Canada
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
INCORPORATION
BY REFERENCE
On
July 13, 2022, the Registrant filed with the Canadian Securities Regulatory Authorities on the System for Electronic Data Analysis and
Retrieval (SEDAR) a material change report, a copy of which is attached hereto as Exhibit 99.2, and which is incorporated by reference
to the Company’s Registration Statement on Form F-10 (File No. 333-261632), as amended and supplemented.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
BELLUS Health
Inc. |
|
|
Date: July 13, 2022 |
By: |
/s/
Ramzi Benamar |
|
|
Name: Ramzi
Benamar
Title: Chief Financial Officer |
Form
6-K Exhibit Index
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Mar 2024 to Apr 2024
BELLUS Health (NASDAQ:BLU)
Historical Stock Chart
From Apr 2023 to Apr 2024